Retrophin, Inc. Purchase Agreements
16 Contracts & Agreements
- Asset Purchase Agreement, dated January 10, 2015, by and between the Company and Asklepion Pharmaceuticals, LLC (Filed With SEC on August 3, 2023)
- Asset Purchase Agreement, dated July 16, 2023, by and between Mirum Pharmaceuticals, Inc., and Travere Therapeutics, Inc (Filed With SEC on July 17, 2023)
- ASSET PURCHASE AGREEMENT (Filed With SEC on August 5, 2016)
- ASSET PURCHASE AGREEMENT BY AND BETWEEN SANOFI AND RETROPHIN, INC. May 22, 2015 ASSET PURCHASE AGREEMENT (Filed With SEC on May 27, 2015)
- PURCHASE AGREEMENT (Filed With SEC on May 11, 2015)
- ASSET PURCHASE AGREEMENT (Filed With SEC on May 11, 2015)
- ASSET PURCHASE AGREEMENT (Filed With SEC on May 11, 2015)
- ASSET PURCHASE AGREEMENT (Filed With SEC on May 11, 2015)
- ASSET PURCHASE AGREEMENT (Filed With SEC on May 11, 2015)
- MEMBERSHIP INTEREST PURCHASE AGREEMENT by and among Retrophin, Inc., on the one hand, and Loring Creek Holdings LLC, Lloyd Glenn and Matthias Kurth (collectively, the Sellers) on... (Filed With SEC on March 31, 2014)
- INTERNATIONAL RIGHTS PURCHASE AGREEMENT (Filed With SEC on March 31, 2014)
- FIRST AMENDMENT TO SECURITIES PURCHASE AGREEMENT (Filed With SEC on January 7, 2014)
- SECOND AMENDMENT TO SECURITIES PURCHASE AGREEMENT (Filed With SEC on January 7, 2014)
- FIRST AMENDMENT TO SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 20, 2013)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 20, 2013)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 19, 2013)